HRT Financial’s Alvotech ALVO Stock Holding History

HRT Financial’s Portfolio ALVO Stock Details ALVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,855	Closed	-$130K	–	2348
2023 Q2	$130K	Buy	+16,855	New	+$157K	﹤0.01%	1935

Other funds holding ALVO

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Lodbrok Capital London, United Kingdom $77.2M AUM 4.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's ALVO Position: Q3 2023 in Review

HRT Financial sold out of Alvotech (ALVO) in Q3 2023, closing a stake of 16,855 shares — an estimated $130K sold.

HRT Financial first reported a position in ALVO in Q2 2023 and held it in 1 quarter. The position peaked at $130K in Q2 2023. 19 funds tracked by Wall St. Rank hold ALVO as of Q3 2023.

HRT Financial reported no remaining Alvotech position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 16,855 Alvotech shares in Q3 2023, an estimated $130K.
HRT Financial first reported a position in Alvotech in Q2 2023 and held it in 1 quarter.
HRT Financial's Alvotech position peaked at $130K in Q2 2023.
19 funds tracked by Wall St. Rank held Alvotech as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.